Compare StocksEW vs TXN

Edwards Lifesciences Corporation (EW) vs Texas Instruments Incorporated (TXN): Which Is the Better Buy in 2026?

As of 2026-09-17, EW is overvalued at $88, with a DCF intrinsic value of $59 and a margin of safety of -49%. TXN is undervalued at $259, with an intrinsic value of $365 and a margin of safety of 29%. Of the two, TXN has the wider margin of safety.

EW
Edwards Lifesciences Corporation
$88.35
VS
TXN
Texas Instruments Incorporated
$259.45

Rewards

EW
  • Edwards Lifesciences Corporation has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 77.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Edwards Lifesciences Corporation scores 80/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
TXN
  • Texas Instruments Incorporated has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
  • Return on equity has consistently exceeded 20% over 4 years, indicating efficient use of shareholder capital.
  • PEG ratio of 0.93 suggests the stock is undervalued relative to its growth rate — paying less than 1x for each unit of earnings growth.

Risks

EW
  • FCF yield of 2.4% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
  • Trailing P/E of 52.6x is 75% above the historical average of 30.1x — the stock trades at a premium to its own history.
  • 10 insider sales totaling $4.4M with no purchases in the past 3 months — insiders are reducing their exposure.
TXN
  • Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • FCF yield of 1.5% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
  • Trailing P/E of 39.5x is 46% above the historical average of 27.1x — the stock trades at a premium to its own history.

Key Valuation Metrics

Learn more →
EW
TXN
Valuation
$1.23B
Free Cash Flow
$3.55B
2.42%
FCF Yield
1.50%
52.59
Trailing P/E
39.49
26.16
Forward P/E
24.37
Quality & Moat
13.43%
ROIC
20.41%
9.18%
ROE
35.18%
77.84%
Gross Margin
58.33%
1.82
PEG Ratio
0.93
Balance Sheet Safety
Net cash
Net Debt / Equity
0.39
N/A
Interest Coverage
N/A
-1.78
Net Debt / EBITDA
0.74
0.00%
Dividend Yield
2.18%
EW: 4Ties: 1TXN: 7
EWTXN

Historical Fundamentals

Learn more →
EW

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

TXN

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
EW
$0.62
created per $1 retained over 3 years
Mediocre Allocator
Σ Retained
$6.65B
Δ Market Cap
+$4.12B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
TXN
$3.91
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$1.96B
Δ Market Cap
+$7.67B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
EW
49.1% Overvalued
Price is 49.1% above estimated fair value
Current Price: $88.35
Fair Value: $59.25
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
TXN
17.9% Margin of Safety
Price is 17.9% below estimated fair value
Current Price: $259.45
Fair Value: $315.99
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
EW

What growth rate is the market pricing in at $88?

+18.5%
Market-Implied Owner Earnings Growth
Standard FCF implies +16.6%

The market implies +18.5% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +16.6%, reflecting heavy growth investment.

TXN

What growth rate is the market pricing in at $259?

+19.9%
Market-Implied Owner Earnings Growth
Standard FCF implies +24.6%

The market implies +19.9% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +24.6%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
EW
80/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Revenue Predictability is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.
TXN
48/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with roic consistency as the key competitive advantage. Improving reinvestment efficiency would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
EW
-2.57
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
TXN
-2.67
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
EW
Insiders 0.2%Institutions 95.7%Retail & Other 4.1%
No. of Institutional Holders1,922
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
TXN
Insiders 0.3%Institutions 91.7%Retail & Other 8.1%
No. of Institutional Holders3,671
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
EW
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
TXN
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
EW
10
Sells (3M)
34
Sells (12M)
Total value (12M): $18.93M
LIPPIS DANIEL J
Officer
$54,169
@ $87.51 · 2026-09-11
DAHL ANDREW M
Officer
$49,534
@ $91.06 · 2026-08-31
BRULS ANNETTE
Officer
$237,907
@ $89.98 · 2026-08-28
CHOPRA DAVEEN
Officer
$2.89M
@ $91.02 · 2026-08-26
MARKOWITZ WAYNE
Officer
$113,417
@ $91.47 · 2026-08-26
LIPPIS DANIEL J
Officer
$56,967
@ $92.03 · 2026-08-11
MARKOWITZ WAYNE
Officer
$12,588
@ $86.22 · 2026-07-30
MARKOWITZ WAYNE
Officer
$818,958
@ $85.06 · 2026-07-28
LIPPIS DANIEL J
Officer
$56,762
@ $91.70 · 2026-07-10
LIPPIS DANIEL J
Officer
$56,577
@ $91.40 · 2026-06-30
DAHL ANDREW M
Officer
$48,853
@ $86.16 · 2026-05-29
CHOPRA DAVEEN
Officer
$126,905
@ $84.60 · 2026-05-22
LIPPIS DANIEL J
Officer
$50,307
@ $81.14 · 2026-05-18
MARKOWITZ WAYNE
Officer
$47,280
@ $79.73 · 2026-05-11
LIPPIS DANIEL J
Officer
$170,160
@ $83.49 · 2026-05-04
ULLEM SCOTT B
Chief Financial Officer
$1.04M
@ $80.04 · 2026-04-09
LIPPIS DANIEL J
Officer
$82,523
@ $80.98 · 2026-04-06
BOBO DONALD E JR
Officer
$1.82M
@ $80.16 · 2026-04-02
LIPPIS DANIEL J
Officer
$87,004
@ $85.38 · 2026-03-11
ULLEM SCOTT B
Chief Financial Officer
$1.10M
@ $84.92 · 2026-03-11
BOBO DONALD E JR
Officer
$974,430
@ $85.93 · 2026-03-02
BOBO DONALD E JR
Officer
$2.01M
@ $83.84 · 2026-02-25
ZOVIGHIAN BERNARD J
Chief Executive Officer
$1.72M
@ $76.67 · 2026-02-12
LIPPIS DANIEL J
Officer
$87,332
@ $85.70 · 2026-01-09
BOBO DONALD E JR
Officer
$971,429
@ $85.66 · 2026-01-06
LIPPIS DANIEL J
Officer
$85,625
@ $84.03 · 2025-12-12
STONE HEISZ LESLIE
Director
$218,120
@ $83.41 · 2025-12-12
BOBO DONALD E JR
Officer
$953,748
@ $83.76 · 2025-12-12
CHOPRA DAVEEN
Officer
$168,750
@ $84.38 · 2025-12-11
BOBO DONALD E JR
Officer
$950,581
@ $83.83 · 2025-12-10
ULLEM SCOTT B
Chief Financial Officer
$650,412
@ $84.47 · 2025-12-09
MARKOWITZ WAYNE
Officer
$50,144
@ $86.01 · 2025-12-08
LIPPIS DANIEL J
Officer
$84,196
@ $82.55 · 2025-11-10
ULLEM SCOTT B
Chief Financial Officer
$1.08M
@ $83.08 · 2025-11-10
CHOPRA DAVEEN
Officer
$204,865
@ $81.95 · 2025-08-25
WOOD LARRY L
Officer
$698,679
@ $78.06 · 2025-08-18
LIPPIS DANIEL J
Officer
$326,900
@ $79.46 · 2025-07-28
WOOD LARRY L
Officer
$673,268
@ $75.23 · 2025-06-16
BOBO DONALD E JR
Officer
$198,911
@ $77.40 · 2025-06-02
CHOPRA DAVEEN
Officer
$112,612
@ $75.07 · 2025-05-22
LIPPIS DANIEL J
Officer
$24,560
@ $74.42 · 2025-05-09
ULLEM SCOTT B
Chief Financial Officer
$837,035
@ $74.40 · 2025-05-09
MARKOWITZ WAYNE
Officer
$20,121
@ $75.08 · 2025-05-07
ZOVIGHIAN BERNARD J
Chief Executive Officer
$447,977
@ $74.91 · 2025-05-05
BOBO DONALD E JR
Officer
$663,196
@ $69.81 · 2025-04-14
LIPPIS DANIEL J
Officer
$21,183
@ $70.61 · 2025-04-08
ULLEM SCOTT B
Chief Financial Officer
$797,267
@ $70.87 · 2025-03-26
BOBO DONALD E JR
Officer
$645,624
@ $67.96 · 2025-03-13
LIPPIS DANIEL J
Officer
$27,792
@ $69.48 · 2025-03-10
ZOVIGHIAN BERNARD J
Chief Executive Officer
$428,448
@ $69.51 · 2025-03-10
ULLEM SCOTT B
Chief Financial Officer
$796,327
@ $70.78 · 2025-02-28
LORANGER STEVEN R
Director
$438,576
@ $76.42 · 2025-02-14
LIPPIS DANIEL J
Officer
$38,170
@ $76.34 · 2025-02-13
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
TXN
1
Sells (3M)
28
Sells (12M)
Total value (12M): $114.87M
ABRAHAM TSEDENIYA
Officer
$1.85M
@ $264.63 · 2026-08-27
CRAIGHEAD MARTIN S
Director
$3.20M
@ $320.43 · 2026-05-28
LIZARDI RAFAEL R
Chief Financial Officer
$14.71M
@ $308.10 · 2026-05-14
BAHAI AHMAD
Officer
$1.55M
@ $309.13 · 2026-05-14
COX CARRIE SMITH
Director
$2.71M
@ $306.41 · 2026-05-13
LEONARD SHANON J
Officer
$1.47M
@ $295.22 · 2026-05-11
ILAN HAVIV
Chief Executive Officer
$5.61M
@ $280.32 · 2026-05-04
KNECHT JULIE C.
Officer
$2.77M
@ $278.70 · 2026-05-01
GARY MARK
Officer
$3.82M
@ $279.25 · 2026-04-30
ROBERTS MARK T
Officer
$7.87M
@ $280.34 · 2026-04-30
YUNUS MOHAMMAD
Officer
$13.82M
@ $270.44 · 2026-04-29
KANE KATHARINE
General Counsel
$1.66M
@ $270.41 · 2026-04-27
BAHAI AHMAD
Officer
$982,359
@ $268.40 · 2026-04-27
RON AMICHAI
Officer
$5.00M
@ $272.43 · 2026-04-24
LIZARDI RAFAEL R
Chief Financial Officer
$11.12M
@ $274.23 · 2026-04-24
WITZSCHE CHRISTINE
Officer
$998,771
@ $275.52 · 2026-04-24
LEONARD SHANON J
Officer
$5.06M
@ $277.95 · 2026-04-24
PATSLEY PAMELA H
Director
$1.19M
@ $276.11 · 2026-04-24
BLUEDORN TODD M
Director
$1.18M
@ $274.25 · 2026-04-24
KOZANIAN HAGOP H
Officer
$1.55M
@ $225.95 · 2026-02-17
LIZARDI RAFAEL R
Chief Financial Officer
$15.88M
@ $221.73 · 2026-02-11
GARY MARK
Officer
$5.24M
@ $226.00 · 2026-02-11
BAHAI AHMAD
Officer
$1.50M
@ $230.79 · 2026-02-11
ROBERTS MARK T
Officer
$986,604
@ $221.16 · 2026-02-09
BLINN MARK A
Director
$696,647
@ $221.58 · 2026-02-05
BAHAI AHMAD
Officer
$670,387
@ $223.46 · 2026-02-05
KIRK RONALD
Director
$1.62M
@ $162.33 · 2025-11-24
WITZSCHE CHRISTINE
Officer
$164,306
@ $164.31 · 2025-11-13
BAHAI AHMAD
Officer
$308,030
@ $205.35 · 2025-08-25
TEMPLETON RICHARD K
Chairman of the Board
$19.85M
@ $195.41 · 2025-02-28
TEMPLETON RICHARD K
Chairman of the Board
$38.65M
@ $199.20 · 2025-02-26
TEMPLETON RICHARD K
Chairman of the Board
$39.32M
@ $202.70 · 2025-02-24
CLARK JANET F
Director
$1.23M
@ $203.62 · 2025-02-24
BLINN MARK A
Director
$1.17M
@ $189.89 · 2025-02-19
LEONARD SHANON J
Officer
$401,241
@ $186.62 · 2025-02-18
BLINN MARK A
Director
$106,617
@ $180.71 · 2025-02-04
KIRK RONALD
Director
$2.14M
@ $203.33 · 2024-11-25
ILAN HAVIV
Chief Executive Officer
$2.88M
@ $219.30 · 2024-11-08
GARY MARK
Officer
$3.49M
@ $219.82 · 2024-11-08
LIZARDI RAFAEL R
Chief Financial Officer
$10.19M
@ $217.16 · 2024-11-07
YUNUS MOHAMMAD
Officer
$1.81M
@ $216.94 · 2024-11-07
BAHAI AHMAD
Officer
$472,514
@ $217.25 · 2024-11-07
GARY MARK
Officer
$940,296
@ $214.83 · 2024-11-06
ILAN HAVIV
Chief Executive Officer
$5.29M
@ $211.50 · 2024-11-06
WITZSCHE CHRISTINE
Officer
$27,941
@ $211.67 · 2024-11-06
SANCHEZ ROBERT E
Director
$2.09M
@ $208.80 · 2024-10-25
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
EW
FearGreed
😐Neutral(58/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
TXN
FearGreed
😐Neutral(50/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
EW
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (58)
TXN
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (50)
View EW Full AnalysisView TXN Full Analysis

Frequently Asked Questions: EW vs TXN

Is Edwards Lifesciences Corporation or Texas Instruments Incorporated more undervalued in 2026?

Based on our discounted cash flow model, TXN trades at a 28.9% margin of safety (intrinsic value $365 vs. price $259), compared to EW's -49.1% margin of safety (intrinsic $59 vs. $88).

Which stock has a wider economic moat, Edwards Lifesciences Corporation or Texas Instruments Incorporated?

EW scores 80/100 (Wide moat), while TXN scores 48/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Which company has better free cash flow, Edwards Lifesciences Corporation or Texas Instruments Incorporated?

Edwards Lifesciences Corporation (EW) generates a 2.4% free cash flow yield, compared to Texas Instruments Incorporated's 1.5%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, Edwards Lifesciences Corporation or Texas Instruments Incorporated?

TXN earns 20.4% ROIC versus EW's 13.4%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

EW vs TXN: Which Is the Better Buy in 2026? | SafetyMargin.io